Obermatt
See Similar Stocks →

Fleury

SAO:FLRY3 · BRFLRYACNOR5
Health Care Providers & ServicesLarge

360

95
EV / EBIT89
Price / Owner Earnings55
Owner Earnings Yield88
Dividend Yield91
Price/Sales83
EV / Gross Profit48
Price/Book67
Return on Capital76
Cash Return on Capital78
Return on Equity74
EBIT Margin92
Gross Profitability21
Cash Conversion74
Accruals70
Owner Earnings Margin94
Sales growth64
Profit Growth81
Long-Term EPS Growth64
Owner Earnings Growth81
Reinvestment89
Price momentum75
Debt load15
Refinancing89
Debt Payback52
Liquidity22
Analyst ratings27
Opinion Changes41
Price Target Upside36
Market mood88
Value Creation20/20strong value creator
  • Creates more value than its capital costs
  • Owner earnings growing
  • Owner earnings per share growing
  • Reinvests at strong returns
  • Solid earnings base

What this means

Fleury generates returns well above its cost of capital, the foundation of durable shareholder value.

Profile

CountryBrazil
IndustryHealth Care Providers & Services
SizeLarge
TypePublic Company
ExchangeBOVESPA
Websitefleury.com.br
ISINBRFLRYACNOR5
Last UpdateApr 2, 2026
Indices
BOVESPA (Brazil)
Themes
Health DiagnosticsOphthalmologyBiomedical EngineeringGeneticsOncologyOrthopaedics

Description

Analysis

Hidden champion

Fleury S.A. is what we call a hidden champion: a strong business that the market is not pricing as one.

The price is attractive. You pay 9.0× its owner earnings: the cash an owner could take out each year, which is in the historically attractive zone. At today's price, the market is assuming roughly -5% yearly growth; analysts expect 18%. The price, in other words, assumes less than the experts do.

The trajectory is moderate and the balance sheet is adequate. The company scores 20/20 on our value-creation score: strong value creator.

What to watch: Some accounting patterns deserve a closer look. As always: this describes the company's numbers; it is not a recommendation.

360° rank · history

1007550250
96
2023202420252026

All-time high

100

Mar 2026

All-time low

62

Jan 2025

Average rank

82

across all years

Detailed & Historical Ranks

Deep dive into 15 detailed ranks and 3 years of history.

Current202520242023
Price/Sales
83
91
82
87
Price/Earnings
86
95
84
83
Price/Book
67
86
73
70
Dividend Yield
91
96
85
96
Value (overall)
95
98
88
95

Cells are coloured by rank band (red weak → green strong). Sentiment & 360° history begins 2023.

Similar Stocks

The companies this stock is ranked against.

Compare Fleury with its peers
Dr. Lal PathLabs
NSI:LALPATHLAB
62
CountryIndia
IndustryHealth Care Providers & Services
SizeMedium
Full Stock Analysis →
Odontoprev
SAO:ODPV3
93
CountryBrazil
IndustryHealth Care Providers & Services
SizeSmall
Full Stock Analysis →
Diagnósticos da América
SAO:DASA3
51
CountryBrazil
IndustryHealth Care Providers & Services
SizeMedium
Full Stock Analysis →
Hapvida Participações e Investimentos
SAO:HAPV3
22
CountryBrazil
IndustryHealth Care Providers & Services
SizeLarge
Full Stock Analysis →
Rede D'Or São Luiz
SAO:RDOR3
88
CountryBrazil
IndustryHealth Care Providers & Services
SizeLarge
Full Stock Analysis →
Apollo Hospitals Enterprise
NSI:APOLLOHOSP
52
CountryIndia
IndustryHealth Care Providers & Services
SizeX-Large
Full Stock Analysis →

Make Sense of the Ranks

Every rank runs 1–100 against true peers. Higher is always better.

360° View
1 · Watch OutGood· 100
Value
1 · ExpensiveGood Value· 100
Quality
1 · Weak FundamentalsHigh Quality· 100
Growth
1 · Tough TimesHigh Growth· 100
Safety
1 · High LeverageWell-Financed· 100
Sentiment
1 · SkepticismPositive· 100
Learn More →